In addition to affecting tumor metastasis, COX‐2‐produced prostaglandin E2 mediates apoptosis inhibition and BCL‐2 synthesis enhancement [60, 61], thereby increasing the risk of DNA damage and cancer. This evidence concerns the gene PTGS2 and neoplasm.